Search Results 241-250 of 4310 for ✍올인구조대 [원탑보증.com/가입코드 111] sbc가입코드 ✍
This observational global registry is intended to collect data without requiring any deviation from the standard of care and IFU in each participating center.
The purpose of this study is to evaluate the effectiveness and safety of PANZYGA in pediatric patients with chronic Immune Thrombocytopenia (ITP). Participation ...
The primary objective of this study is to evaluate whether selonsertib (SEL; GS-4997) can cause fibrosis regression and reduce associated complications in ...
A Study to Evaluate the Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses.
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... . VID-20464900. Home; Mayo Clinic Treatment Center. Fuel groundbreaking medical research! Give Today. Your donation powers the future of medicine and ...
About this study. Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, ...
Tinostamustine (EDO-S101) is a new chemical entity, an AK-DAC (a first-in-class alkylating deacetylase inhibiting molecule) that, in preclinical studies, has ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.